
OneCell is a telemedicine platform with AI designed for pathology laboratories to accelerate and improve the accuracy of oncological disease diagnosis. It offers AI-powered automation for routine microscopic analysis tasks, including quantitative cell analysis, histological tissue segmentation, and tumor type classification. The platform includes a digital atlas for archiving microscopic samples with semantic search capabilities, smart image storage algorithms reducing storage costs by 8 times, and a telepathology platform connecting doctors for remote consultations and second opinions. OneCell also provides hardware and software solutions to convert any microscope into a scanner, enabling efficient scanning and online consultations. The company collaborates with leading oncology and pathology institutions and emphasizes data security and cost efficiency in medical imaging storage.

OneCell is a telemedicine platform with AI designed for pathology laboratories to accelerate and improve the accuracy of oncological disease diagnosis. It offers AI-powered automation for routine microscopic analysis tasks, including quantitative cell analysis, histological tissue segmentation, and tumor type classification. The platform includes a digital atlas for archiving microscopic samples with semantic search capabilities, smart image storage algorithms reducing storage costs by 8 times, and a telepathology platform connecting doctors for remote consultations and second opinions. OneCell also provides hardware and software solutions to convert any microscope into a scanner, enabling efficient scanning and online consultations. The company collaborates with leading oncology and pathology institutions and emphasizes data security and cost efficiency in medical imaging storage.
What they do: AI-enabled diagnostics platform focused on pathology and oncology (cell/CTC analysis, telepathology, digital atlas)
Founded / HQ hint: Founded (entity OneCell.ai / OneCell LLC) — associated with Santa Clara, California in Crunchbase
Funding (reported): $16M Series A reported; prior total funding entry of $6M (recorded)
Pathology diagnostics and oncology (microscopy automation, telepathology, circulating tumor cell analysis in related OneCell entities).
Health care; Medical diagnostics
$16,000,000
Reported participation from Tenacity Ventures, Cedars‑Sinai, Eragon Ventures, and Singularity Venture Partners for OneCell Diagnostics/OneCell reporting
$6,000,000
Recorded total funding amount entry